中国人体免疫保健品行业主要企业有Nutramax Laboratories, Cellderm Technologies Inc., EuroPharma Inc., Bio-Tech Pharmacal Inc., NutriGold Inc., Alticor Inc., USANA Health Sciences, Danisco A/S, Seroyal International Inc ...

03, 2024 (GLOBE NEWSWIRE) -- Bio-Path Holdings, Inc., (NASDAQ:BPTH), a biotechnology company leveraging its proprietary DNAbilize® liposomal delivery and antisense technology to develop a ...

Shah currently serves as Deputy CFO at Adani Enterprises Limited. Sep 14, 2024 20:22 Lumax Acquires Majority Stake in Greenfuel Energy Solutions Lumax Auto Technologies acquires majority stake in ...

It is supported by the National Root Crops Research Institute and the CIP as part of the Feed the Future Global Biotech Potato Partnership with support from the African Agricultural Technology ...

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...

Jitendra Singh at the inaugural ceremony of Global Bio India 2024 here today at Pragati Maidan. Addressing the inaugural ceremony in virtual mode,Union Minister of State (Independent Charge) for ...

The Indian Institute of Science has unveiled a revolutionary 'brain on a chip' technology that can store and process data in 16,500 states within a molecular film. This neuromorphic computing ...

TEMPE, Ariz., Sept. 12, 2024 /PRNewswire/ -- GT Medical Technologies, Inc. (“GT MedTech” or the “Company”), a medical device company with a corporate purpose of improving the lives of patients with ...

The company has also removed the HR and hiring platform Workday from its tech stack, a Klarna spokesperson confirmed to Inc. This may be only the beginning of Klarna's automation spree.

today announced it has provided a $35 million venture loan facility to GT Medical Technologies, Inc. (“GT MedTech”), of which $15 million has been initially funded. GT MedTech, through its innovative ...

Cellino Biotech, which was founded in 2017, won a federal grant worth up to $25 million to continue to develop its advanced biomanufacturing technology. Dubbed NEBULA, the system aims to scale the ...